XML 13 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Expenses:    
Research and development $ 3,034,152 $ 1,882,345
General and administration expenses 2,313,870 694,954
Total Operating Expenses 5,348,022 2,577,299
Loss From Operations (5,348,022) (2,577,299)
Other Income (Expenses):    
Interest income 28,749 39,390
Loss Before Income Taxes (5,319,273) (2,537,909)
Provision for Income Taxes 1,600 1,589
Net Loss $ (5,320,873) $ (2,539,498)
Net Loss Per Share:    
Basic and Diluted $ (0.3) $ (0.15)
Weighted average number of shares used in computing basic and diluted net loss per share:    
Basic and Diluted 17,864,769 16,589,633